ArticlePulmonary therapy2025

Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label Extension.

Nick H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.